UAS Labs probiotics seized for drug claims on labels

At the request of the U.S. Food and Drug Administration (FDA), US Marshalls have seized products including DDS Acidophilus, DDS Plus, Probioplus DDS, DDS Junior, and Cran-Gyn DDS, in capsule, powder, and tablet forms.

Nobody from UAS Labs was available for comment prior to publication.

According to FDA, the company made claims that the products could treat or prevent colds, flu, respiratory infections, urinary tract infections, yeast infections, ulcers, and high cholesterol. Such claims are in violation of the Federal Food, Drug, and Cosmetic Act.

The Minnesota-based company was reportedly warned by FDA that its products were in violation of federal law following, and a March 2011 inspection revealed that the company continued to make disease claims for the products, said the agency.

According to the complaint filed in U.S. District Court for the District of Minnesota: “UAS Laboratories' products did not conform to any existing monograph, nor did the company file or receive approval of a new drug application, and the products are not generally recognized as safe and effective for their recommended uses”​.

More to follow.​